Modular Medical appoints Jeff Goldberg, insulin delivery veteran, to Board

Modular Medical, Inc.

Appointed Jeff Goldberg to Board effective May 22, 2025.
Goldberg currently chairs Lannett Company, a generic pharma manufacturer that has launched generic insulin.
Previously served as President/CEO at IncuMed, Alfred E. Mann's incubator, overseeing insulin patch-pump program.
Also serves on boards of ATI Physical Therapy, Cano Health, and Eating Recovery Centers.
CEO Jeb Besser cited Goldberg's unique background at intersection of affordable drug-device combinations.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey Goldberg

Director

MODD · Modular Medical, Inc.

Effective: 2025-05-22
Filed: May 28, 2025, 7:59 PM ET

Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey Goldberg was appointed as Director at Modular Medical, Inc..

Action: appointed
Role: Director

Exact text from the filing

Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.

View on SEC.gov

Modular Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-048276

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.